Noninvasive Spinal Stimulation for Stroke Recovery
Trial Summary
What is the purpose of this trial?
This study has two interventional components, the first is a cross-over design and the second is a randomized control trial. Both will evaluate the effectiveness of transcutaneous (non-invasive) spinal cord stimulation on gait and balance function for individuals with hemiplegia due to stroke.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but you cannot participate if you are taking medications that affect motor system excitability, like amphetamines or lorazepam.
What data supports the effectiveness of this treatment for stroke recovery?
Research shows that transcutaneous electrical spinal cord stimulation (tSCS) can activate spinal networks to improve walking in stroke patients, as seen in a study where patients with hemiparesis showed clinically important improvements in walking after using tSCS. Additionally, similar noninvasive spinal stimulation techniques have been effective in enhancing motor recovery in spinal cord injury, suggesting potential benefits for stroke rehabilitation.12345
Is noninvasive spinal stimulation safe for humans?
Research on transcutaneous electrical spinal cord stimulation (tSCS) suggests it is generally safe for humans, as it is a non-invasive method used in rehabilitation for various conditions, including stroke and spinal cord injuries. Studies have shown it can activate spinal circuits and improve motor functions without significant safety concerns.12367
How does the treatment of noninvasive spinal stimulation for stroke recovery differ from other treatments?
Noninvasive spinal stimulation for stroke recovery is unique because it uses electrical stimulation to activate spinal networks that control walking, which can improve walking ability in stroke patients. This approach is non-invasive and targets the spinal cord directly, unlike traditional therapies that may focus on physical exercises alone.12356
Research Team
Arun Jayaraman, PT, PhD
Principal Investigator
Shirley Ryan AbilityLab
Eligibility Criteria
This trial is for adults over 18 who have hemiplegia from a stroke at least 6 months ago and need some help walking. They shouldn't be getting regular physical therapy, must have doctor's approval to join, and can't be pregnant or nursing. People with seizures unrelated to stroke, certain neurological conditions, severe muscle tightness in legs, recent Botox in the leg, metal implants in head/face or using heart devices like pacemakers are excluded.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Exploratory Phase
Identify optimal stimulation parameters and gait training protocol for each individual patient with stroke
Treatment
Participants undergo transcutaneous spinal cord stimulation and gait training to evaluate short-term and long-term effects on gait symmetry and performance
Follow-up
Participants are monitored for safety and effectiveness after treatment, including assessments at 3 months post-intervention
Treatment Details
Interventions
- Conventional gait training
- Exploratory Phase
- Noninvasive spinal stimulation
- Noninvasive spinal stimulation with gait training
- Sham
Conventional gait training is already approved in United States, European Union, Canada for the following indications:
- Stroke Rehabilitation
- Hemiplegia
- Gait Disorders
- Stroke Rehabilitation
- Neurological Rehabilitation
- Physical Therapy
- Stroke Rehabilitation
- Hemiplegia
- Gait Disorders
Find a Clinic Near You
Who Is Running the Clinical Trial?
Shirley Ryan AbilityLab
Lead Sponsor
University of California, Los Angeles
Collaborator